Clinical trials recruiting for Solid Tumor Cancer
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| GV20-0251 | 1 |
| HLX43 dose 1 | 1 |
| HLX43 dose 2 | 1 |
| HLX43 dose 3 | 1 |
| HLX43 dose 4 | 1 |
| HLX43 dose 5 | 1 |
| LXP1788 is administered intravenously via Port-A | 1 |
| PLT012 | 1 |
| SYS6043 | 1 |
| Serplulimab | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Texas | 2 |
| Alaska | 1 |
| California | 1 |
| Florida | 1 |
| Missouri | 1 |
| Virginia | 1 |
Top cities
Self-screener
Recruiting trials
- A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
- A Phase I Study of LXP1788 Injection with Advanced Solid Tumors.
- A Phase Ib/II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Patients With Advanced/Metastatic Solid Tumors
- Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
- Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial
- Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
- Study of GV20-0251 in Participants With Solid Tumor Malignancies
Related conditions
Trials recruiting for Solid Tumor Cancer often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Solid Tumor Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.